Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Severity of Alopecia Tool (SALT)
The proportion of postmenopausal breast cancer patients on endocrine therapy who experience grade S1 to S5 alopecia as defined by the Severity of Alopecia Tool (SALT).
University Health Network-Princess Margaret Hospital
Canada: Research Ethics Board